A multidisciplinary group has been assembled to undertake a cooperative effort devoted to the expression and purification of HIV proteins and the development of experimental and theoretical methods to study their structures. The expression, purification and scale-up efforts described in Program 1 will be concerned with the virally encoded HIV proteins, tat-III trans-activator, reverse transcriptase, the highly specific protease responsible for the cleavage of the Pr-gag and Pr-gag-pol proteins to their mature virion proteins, and Pr-gag, the substrate for the protease. In Program 2, theoretical methods will be undertaken to develop procedures for the design of inhibitors for a number of enzymes involving methods based upon fitting and matching topological features to active sites. Program 3 deals with the development of robotic control of procedures to study automated methods for crystallization of peptides and proteins and investigation of their structures, investigation of a trypsin-trypsin inhibitor complex by X-ray crystallography and theoretical studies on solvation energies and methods for predicting complementarity at protein interfaces. The efforts in Program 4 will be directed to the design of new NMR pulse sequences to facilitate the acquisition and the derivation of information on the structure and dynamics of proteins, including the HIV encoded proteins tat-III and the gag- pol protease. The efforts of Program 5 will be concerned with the development and application of new mass spectrometric methods to study HIV encoded coat glycoproteins, GP-160 and GP-120, and the T4 receptor. The proposed studies will be concerned with determining the structures of the oligosaccharide components and their functional significance in these glycoproteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM039526-02
Application #
3096293
Study Section
(SRC)
Project Start
1987-09-01
Project End
1992-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Smithkline Beecham, Plc
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19101
Stebbins, J; Debouck, C (1997) A microtiter colorimetric assay for the HIV-1 protease. Anal Biochem 248:246-50
Stebbins, J; Deckman, I C; Richardson, S B et al. (1996) A heterologous substrate assay for the HIV-1 protease engineered in Escherichia coli. Anal Biochem 242:90-4
Rodgers, D W; Gamblin, S J; Harris, B A et al. (1995) The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 92:1222-6
Taylor, P B; Culp, J S; Debouck, C et al. (1994) Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors. J Biol Chem 269:6325-31
Toniolo, C; Crisma, M; Fabiano, N et al. (1994) A crystal-state, solution and theoretical study of the preferred conformation of linear C alpha, alpha-diphenylglycine derivatives and dipeptides with potential anticonvulsant activity. Int J Pept Protein Res 44:85-95
Stebbins, J; Debouck, C (1994) Expression systems for retroviral proteases. Methods Enzymol 241:3-16
Huddleston, M J; Bean, M F; Carr, S A (1993) Collisional fragmentation of glycopeptides by electrospray ionization LC/MS and LC/MS/MS: methods for selective detection of glycopeptides in protein digests. Anal Chem 65:877-84
Rodriguez, E J; Debouck, C; Deckman, I C et al. (1993) Inhibitor binding to the Phe53Trp mutant of HIV-1 protease promotes conformational changes detectable by spectrofluorometry. Biochemistry 32:3557-63
Dreyer, G B; Boehm, J C; Chenera, B et al. (1993) A symmetric inhibitor binds HIV-1 protease asymmetrically. Biochemistry 32:937-47
Carr, S A; Huddleston, M J; Bean, M F (1993) Selective identification and differentiation of N- and O-linked oligosaccharides in glycoproteins by liquid chromatography-mass spectrometry. Protein Sci 2:183-96

Showing the most recent 10 out of 29 publications